Humira, Remicade, Similar Drugs May Increase Risk of New Onset Psoriasis: Study
Drugs like Humira and Remicade, designed to treat autoimmune disorders, may increase the risk of new onset psoriasis, according to the findings of a new study.
Drugs like Humira and Remicade, designed to treat autoimmune disorders, may increase the risk of new onset psoriasis, according to the findings of a new study.
A case report warns of potentially extreme and deadly skin reactions linked to use of the cancer drug Tagrisso.
A new study links air pollution exposure to an increased risk of psoriasis flare ups.
The findings of a new study indicate Humira and Remicade can increase the risk of serious infections in patients with psoriasis.
A new study warns that Stelara can significantly increase the risk of heart problems and strokes among patients already at a high risk of coronary events.
Novartis has filed a lawsuit against Johnson & Johnson claiming it is using misleading advertising to promote the psoriasis drug Tremfya, which omits critical safety data.
A new ISMP report warns that the psoriasis drug Stelara appears to be linked to a high rate of cancer.
Humira and Enbrel were the drugs most linked to injury reports last year, including injection site reactions, infections and cases of cancer, according to a new report.
A new study reveals that some dermatologists are prescribing steroids to psoriasis patients in defiance of medical guidelines on treating the skin condition.
The first trial over claims that the recalled psoriasis drug Raptiva caused a fatal brain infection has been pushed back to June.